Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Marc Michel Noel und 8 weiteren Autor:innen. Beteiligte Einrichtung: CHU Rouen, Vascular Hemostasis Unit, Rouen, France. Hauptthemen laut MEDLINE: Blood Platelets, Thrombocytopenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Immature platelets (IP) are the youngest circulating platelets, released from megakaryocytes, and demonstrating increased dimensions, significant RNA content, and enhanced activity. Immature platelet research focuses on a differential diagnostic help in patients with thrombocytopenia. The objectives of this study were to compare the variability of IP in citrate and EDTA samples, and to determine stability over time.
Methods
Fifty‐six patients were included for comparison between EDTA and citrate whole blood sample collection. Among the patients, 28 had thrombocytopenia (platelet count < 150G/L). Platelet measurement impedancemetry and fluorimetry were performed with Sysmex XN‐9000. The immature platelet fraction (IPF) and absolute immature platelet count (A‐IPC) were determined with a fluorescent method.
Results
The mean value of platelet count with fluorescence was, in EDTA sample, 215 ± 171 and, in citrate sample, 153 ± 118 G/L. No significant difference was observed between IPF between EDTA and citrate (7.74 ± 6.68% vs. 8.45 ± 7.37%, p = 0.69), respectively. With the Bland–Altman analysis, the mean difference in the EDTA sample, between 1 and 24 h, was 8.06 ± 6.96% and 8.73 ± 7.12% for IPF, whereas in the citrate sample, between 1 and 6 h, it was 8.60 ± 7.29% and 7.54 ± 6.97%, for IPF. Comparing 1 h EDTA sample with 6 h citrate sample, the variance ratio was 0.974 (95% CI: 0.864–1.084) in IPF.
Conclusions
We confirmed the potential to conduct IP measurements up to 24 h in the EDTA sample and IPF measurements in the citrate sample for up to 6 h. These results may be useful for the use of IPF, which is a promising parameter whose interest in clinical practice and standardization is not yet well defined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU Rouen, Vascular Hemostasis Unit, Rouen, France.
- Univ ROUEN, INSERM U1096, Rouen, France.
- General Biochemistry, CHU Rouen, Rouen, France.
- Rouen, France Hematology laboratory, CHU Rouen, Rouen, France.
ORCID-Profile: Marc Michel Noel, Paul Billoir
Zitieren
APA
Noel, M. M., Feugray, G., Kasonga, F., Buchonnet, G., Daliphard, S., Barbay, V., Bera, E., Le Cam Duchez, V., & Billoir, P. (2023). Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24946
Vancouver
Noel MM, Feugray G, Kasonga F, Buchonnet G, Daliphard S, Barbay V, et al. Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24946
BibTeX
@article{Noel2023,
author = {Noel, Marc Michel and Feugray, Guillaume and Kasonga, Fiston and Buchonnet, Gérard and Daliphard, Sylvie and Barbay, Virginie and Bera, Elsa and Le Cam Duchez, Véronique and Billoir, Paul},
title = {Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24946}
}
EUVIMED